Transcript Highlights:

• to re-shore very critical supply chains back to the United States of America, not only through pharmaceuticals
• So we manufacture various high-purity inorganic and organic salts for nutrition, food, pharmaceuticals
• it is more suitable for a startup, technology, testing, or perhaps a sterile filling line for pharmaceuticals
• Just a little background: the API Innovation Center, API stands for active pharmaceutical ingredients
• They work in partnership with UMSL to help create new efficiencies in pharmaceutical production.

Keywords: 959, house, all

Transcript Highlights:

• They have the same problems they had before, compounded by the pain and trauma of losing healthy body
• They have the same problems they had before, compounded by the pain and trauma of losing healthy body
• /c><02:38:25.040><c> by</c><02:38:25.280><c> the</c><02:38:25.439><c> pain</c> they had before, compounded
• by the pain they had before, compounded by the pain and<02:38:26.000><c> trauma</c><02:38:26.880><c>
• pay the lobbyists that pharmaceuticals pay the lobbyists that are<03:04:38.080><c> in</c><03:04:38.319

Keywords: 1191, senate, all

Transcript Highlights:

• Currently, most active pharmaceutical ingredients, APIs, are manufactured in China and India.
• This would support broader pharmaceutical sector growth, technological advancement, and assist in efforts
• That's the industry I came from, and I used to deal with all these CEOs of these large pharmaceutical
• And, you know, I keep hearing that New Jersey gets a lot of the medical, the pharmaceutical companies
• And you're in pharmaceuticals. Okay, just real quick, then, you're in pharmaceuticals.

Summary: The committee first heard House Bill 2896, sponsored by Rep. Brown, which would change how boards of governors for state universities are selected. Brown said the bill, developed with input from the governor’s office, would simplify appointment rules by removing service-area and congressional-district requirements and instead limiting board membership so no more than half of the voting members come from the county where the institution is located, with a St. Louis exception. Members asked about Missouri residency requirements, the effect on Missouri State University and Southeast Missouri State University, and whether university presidents would recommend candidates to the governor. Brown said he would follow up on questions and was open to discussing possible adjustments, especially regarding geographic representation. One witness spoke in favor, arguing that boards should reflect a cross-section of the state. No opposition was presented, and the hearing on HB 2896 was closed. The committee then took up House Bill 1659, the Missouri Defense and Energy Independence Act, sponsored by Rep. Steinmeyer. The bill would create a grant program to help Missouri manufacturers convert facilities to produce strategic materials tied to national defense and energy resilience. Steinmeyer described it as a private-capital-first program requiring at least $500,000 in private investment, with grants capped at $1 million per project per year, subject to appropriation, annual reporting, and repayment provisions if projects fail. He said the bill is intended to attract investment, create jobs, and strengthen supply chains while keeping taxpayer risk limited. Members raised concerns about environmental and public safety risks, the bill’s placement in the higher education committee, whether it should instead be funded federally, and whether the program would mainly benefit large companies rather than small businesses. Questions also focused on the bill’s workforce-development component, the lack of detail on training and public-health protections, and the budget impact of creating a dedicated fund that would retain money and interest rather than sweep it to general revenue. Steinmeyer said the bill is meant to support existing Missouri companies or companies establishing headquarters in Missouri, and that universities had been involved in discussions about workforce needs. A representative from the API Innovation Center testified in favor, saying the bill could help develop key starting materials for pharmaceuticals and support reshoring. One witness testified in opposition, arguing the state should not subsidize private industry and warning about fiscal strain and environmental oversight. No vote was taken, and the hearing concluded without further action.

Transcript Highlights:

• If not, they compound. So children are desperately in need of both of these items.
• use is still legal in many states, victims of these practices are silenced or disbelieved, which compounds
• He also had the support of his current employer, a major pharmaceutical firm.

Keywords: 995, all

Summary: The committee held a hybrid hearing on a range of bills affecting children, families, disability rights, homelessness, and social services. Early testimony focused on H.215, which would support children experiencing homelessness by speeding access to child care vouchers and early intervention screenings. Boston officials, Horizons for Homeless Children, Head Start, pediatric and early education advocates, and families described delays in child care and early intervention, the developmental risks of homelessness, and the need for automatic referrals and faster access to services. Testimony also supported H.216, which would improve emergency housing assistance by restoring presumptive eligibility, reducing documentation barriers, extending shelter stays from six to nine months, and creating an ombudsperson; providers and legal advocates said current rules leave families sleeping in cars or outside and create unnecessary administrative hurdles. The committee also heard strong support for H.210, which would repeal the “Learn Fair” school attendance sanction that cuts cash assistance to families when children miss school. Advocates from legal aid, education, and anti-poverty organizations argued the policy is punitive, burdensome, and ineffective, disproportionately affecting low-income, disabled, and Hispanic/Latino families. Several speakers said chronic absenteeism should be addressed through supports such as family outreach, wraparound services, and school engagement rather than benefit cuts. Legislators and school officials from Salem also testified that their districts reduced absenteeism through supportive strategies, not sanctions. Additional testimony addressed children’s vision bills H.202 and H.166, with optometrists and researchers urging better screening, data systems, and treatment access to close achievement gaps caused by untreated vision problems. Senator Lovely also presented S.2714, proposing a study of discrimination in public accommodations for people with service animals. Later, testimony on H.279 supported changing social work licensure rules to remove exam requirements that speakers said disproportionately exclude multilingual candidates and candidates of color. The hearing also included testimony on bills related to the Judge Rotenberg Center and electric shock devices, with disability rights advocates opposing continued use of the devices and urging the committee to reject licensing or authorization for them. No votes or committee actions were taken during the hearing.

Transcript Highlights:

• So through either compounding or manufacturing, we have the supplies we need to add magnesium or vitamin
• So through either, uh, uh, compounding, indoor, uh, manufacturing, we have the supplies we need to add
• I think, again, we are required CEs every year in pharmaceutical medications.

Summary: The committee heard several bills related largely to Arizona’s behavioral health and Access system, plus a fertility coverage mandate, a state hospital admissions bill, and a naturopathic scope-of-practice bill. SB 1114 would appropriate $1 million to the Maricopa County Attorney’s Office for investigations into behavioral health patient brokering; the sponsor described ongoing fraud involving vulnerable Native American patients, while some members questioned why the Attorney General was not handling the work. The bill passed 10-1 with one present. SB 1116 would require claim denials and appeal determinations for American Indian Health Program behavioral health services to be reviewed by someone with at least two years of relevant clinical experience; Access said it was neutral but raised concerns about vague language and added staffing needs, and the bill passed 7-4 with one present. SB 1346 would require Access to notify providers of claim deficiencies within 72 hours and approve or deny corrected claims within 10 business days; supporters said it would reduce long delays and unpaid claims, while Access said it would need more staff and system changes. The bill passed 7-5. The committee also approved SB 1347, which requires insurance coverage for fertility preservation services for cancer patients of reproductive age whose treatment is likely to cause infertility, with a religious-employer exemption. Supporters, including cancer survivors and an advocacy representative, said the bill protects patients who must make rapid decisions before treatment begins; insurers were neutral. The bill passed unanimously 12-0. SB 1813 would require the Arizona State Hospital to admit patients based on clinical need rather than county of residence, effectively ending the Maricopa County cap tied to the Arnold v. Sarn settlement. Supporters argued the cap leaves seriously ill patients waiting in other facilities for long periods, while ADHS warned of possible litigation and rural access concerns; the bill passed 9-2 with one present. Finally, the committee began hearing SB 1178, which would allow naturopathic physicians to administer certain antibiotics, antivirals, and antifungals intravenously. The sponsor argued naturopaths should be able to practice to the full scope of their training amid physician shortages, while the Arizona Medical Association and osteopathic representatives opposed the bill, saying IV antimicrobials are high-risk therapies that require hospital-level training, monitoring, and stewardship. Testimony focused on patient safety, appropriate setting, and whether the bill should be narrowed or amended; no vote on SB 1178 was taken in the portion provided.

Transcript Highlights:

• Um, also looking at systematic pharmaceutical treatments, uh, with the, uh, Texas Parks and Wildlife
• Well, now you're adding a dose on top of an existing dose, and, and so it may compound the issue.
• Compounding the problem is a lack of enforcement and surveillance in Mexico, where screw worm continues

Transcript Highlights:

• I'm Senior Director of State Affairs at Pharmaceutical Care Management Association, otherwise known as
• Pharmaceutical manufacturers are refusing to ship 340B-priced drugs to CHC, or community health center
• It also requires pharmaceutical manufacturers to ship 340B-priced drugs to pharmacy health centers and
• HDA is the national trade association representing pharmaceutical wholesale distributors.
• HDA is the national trade association representing pharmaceutical wholesale distributors.

Keywords: 995, all

Summary: The committee held a lengthy hearing on a large docket of pharmacy and drug-pricing bills, with most testimony focused on PBM reform, 340B drug discount program protections, specialty medication access, and medication adherence. Chair James Murphy and Senator Paul Feeney opened the hearing and took testimony from legislators, patient advocates, pharmacists, health center leaders, industry representatives, and policy groups. Several speakers described delays, denials, high out-of-pocket costs, and pharmacy closures tied to PBM practices, while others emphasized the importance of community health centers and independent pharmacies in serving patients. On the 340B program, supporters including Senator Eldridge, Senator Payano, Community Care Cooperative, Fenway Health, the Massachusetts League of Community Health Centers, and several community health center leaders argued that bills such as H. 1107 and S. 819 would stop discriminatory PBM and manufacturer practices, preserve contract pharmacy access, and protect safety-net providers that say they reinvest savings into care, pharmacy expansion, interpreter services, behavioral health, and other services. Opponents including PhRMA, the Community Liver Alliance, and a public policy analyst argued the program lacks transparency and accountability, has grown beyond its original purpose, and may benefit large hospitals and for-profit entities more than low-income patients. They urged more reporting and oversight rather than expanding protections. On PBM reform, testimony supported bills including H. 1157, H. 1234, S. 724, S. 831, and related measures that would require rebate pass-through, ban spread pricing, limit steering to PBM-owned pharmacies, and improve reimbursement for community pharmacies. Independent pharmacists and patients said current PBM practices raise costs, create administrative burdens, and threaten access to local pharmacies. PCMA, representing PBMs, opposed the reforms, arguing PBMs lower costs, that plan sponsors choose to contract with them, and that the Health Policy Commission and CHIA should complete their ongoing study before new mandates are adopted. The committee also heard support for H. 1322 and S. 734 on specialty medications, and for H. 781 and H. 1305 on medication synchronization to improve adherence. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• Currently, most active pharmaceutical ingredients, APIs, are manufactured in China and India.
• And I used to deal with all these CEOs of these large pharmaceutical companies.
• Okay, just real quick then, you're in pharmaceuticals. Just help me connect the dots.
• They're already doing some pharmaceuticals that are generic, so anyway.
• They're already doing some pharmaceuticals that are generic, so anyway.

Keywords: 959, house, all

Transcript Highlights:

• definition of cannabis to include non-intoxicating cannabinoids such as CBD and other hemp-derived compounds
• 08:40.839><c> uh</c> such as CBD and other hemp derived uh such as CBD and other hemp derived uh compounds
• the</c><00:08:42.320><c> bill</c><00:08:42.640><c> provides</c><00:08:43.080><c> alternative</c> compounds
• the bill provides alternative compounds the bill provides alternative treatment<00:08:44.080><c> centers
• With that said, I'm not aware of any pharmaceutical that we allow people to produce at home because of

Keywords: 1189, house, all

Transcript Highlights:

• In food deserts, this food affordability crisis compounds.
• Dietary supplements are not regulated like pharmaceutical drugs.
• Yet over the last decade, more than 750 supplement brands have been found to be tainted with pharmaceutical
• Between 2007 and 2016, the FDA identified 776 dietary supplements with active pharmaceutical ingredients

Summary: The committee heard several immigration-, health-, food access-, and tribal-rights-related bills. AB 1725 would require disclosure of oil wells near homes and sensitive sites and stronger methane monitoring; supporters described health and safety harms in communities near wells, while apartment, realtor, building, and chamber representatives opposed or sought amendments, arguing the bill should better target the responsible industry and fit existing disclosure processes. AB 1650 would require privately rented or leased vehicles used by government agencies for enforcement to be clearly identifiable and equipped with safety lighting; supporters, including immigrant-rights advocates and local officials, said unmarked vehicles create fear and confusion during ICE operations, while the chamber sought clarification and noted exemptions for ordinary undercover law enforcement. AB 1857 would prohibit grocery restrictive covenants that keep new supermarkets from opening after a store closes, with supporters framing it as a food-access and anti-hunger measure; grocers and retailers raised concerns but said amendments addressed many issues, and the committee moved the bill forward as amended to Appropriations on a recorded vote, with all members present voting aye except one absent member and the bill placed on call. The committee also heard AB 1876, which would codify federal health-care nondiscrimination protections in state law. Supporters from Equality California, Disability Rights California, Planned Parenthood, and other health groups said it would preserve coverage protections for LGBTQ people, people with disabilities, and other protected classes amid federal rollbacks; opponents argued it would entrench gender-affirming-care standards and criticized the underlying medical framework. The bill passed to Appropriations on a recorded vote, with most members voting aye and one no vote, and was placed on call. AB 1908 would allow public entities to use judgment obligation bonds to finance self-funded victim compensation funds; Los Angeles County said the bill would fill a financing gap for faster compensation, and the committee advanced it on a recorded vote and placed it on call. AB 1881, the California Indian Freedom Act of 2026, would protect California tribes’ access to sacred sites and traditional practices on state public lands and require meaningful consultation; it drew extensive support from tribal leaders and Native organizations, while cities, counties, utilities, builders, and business groups were opposed unless amended, largely seeking clarification and narrowing. The bill was amended to focus on state public lands and passed to Appropriations on a recorded vote, then placed on call. Later, AB 2465 would bar businesses that profit from private detention facilities or contract with immigration-enforcement agencies from receiving state grants, loans, or tax credits and create an immigrant resilience fund. Supporters said the state should not subsidize businesses tied to immigration raids and detention; opponents, including the chamber, bankers, and contractors, raised vagueness and scope concerns, especially over what contracts would be covered. Members said they supported the concept but wanted the bill tightened, and it passed to Revenue and Taxation on a recorded vote with one no vote and was placed on call. The committee then heard AB 2662, which would create a formal state process to monitor and report on federal immigration enforcement actions and their impacts; supporters from legal aid and health centers said raids have chilled access to work, schools, clinics, and naturalization, and the bill was presented as a modest accountability measure. The transcript cuts off before any vote on AB 2662. The committee also approved a consent calendar of several bills and resolutions, sending some to Appropriations and others to the floor.

Transcript Highlights:

• Texas has over 13,000, nearly 14,000 jobs in the pharmaceutical industry. pharmaceutical development
• Those restrictions come from the pharmaceutical manufacturers themselves.
• The transparency, I mean, where is the transparency on the pharmaceuticals?
• Evidence supports the idea that pharmaceuticals are still making a lot of money.
• Their pharmaceutical coverage.

Bills: HB712, HB722, HB946, HB1687, HB1809, HB1899, HB2528, HB2583, HB2741, HB2750, HB3021, HB3150, HB3265, HB3658, HB3812, HB3960, HB4392, HB4432

Keywords: prostate cancer, health benefit plans, insurance coverage, cost sharing, preventive health care, auto insurance, total loss evaluation, disclosure, insurance materials, vehicle appraisal, HB 946, Texas Insurance Code, automobile insurance claims, oral release, written release, settlement agreement, claim release, property damage, bodily injury, psychological injury

Transcript Highlights:

• ...asked the pharmaceutical companies to ask the U.S.
• </c> for the top 10 CEOs of pharmaceutical for the top 10 CEOs of pharmaceutical manufacturer manufacturer
• All it's going to do is increase the bottom line of pharmaceutical manufacturers.
• This is funded through pharmaceutical companies providing these discounts to us.
• This is funded through pharmaceutical companies providing these discounts to us.

Keywords: 00:00:00 Call to Order/Roll Call 00:01:19 Discussion of 25RS HB 785 00:30:25 Roll Call Vote on 25RS HB 785 00:32:15 Discussion of 25RS HB 61 00:36:42 Roll Call Vote on 25RS HB 61 00:38:07 Discussion of 25RS HB 788 00:51:01 Discussion of 25RS SB 14 01:11:09 Discussion of 25RS HB 685 01:44:57 Adjournment, 958, all

Summary: The House Standing Committee on Health Services met with a quorum and took up House Bill 785, as amended by a committee substitute that combined language from HB 785 and HB 787. The bill was described as addressing Medicaid managed care organization (MCO) audits, provider contract notice and amendment procedures, mental health parity compliance, and related transparency requirements. Supporters said the measure would tighten notice to providers, limit repeated contract amendments and rate reductions, require more standardized audit procedures, and add reporting on Medicaid claims, appeals, and grievances. It also includes a provision requiring coverage of at least two evaluation-and-management billable services per physician per recipient per date of service, and a section addressing narcotic/opioid treatment program licensing and reimbursement language. Testimony in support came from Representative Kim Moore, John Inman of BrightView Health, Michelle Sandborne of the Children’s Alliance, and Kelly Cormic of RYSE. They argued that MCOs often use audits and recoupments in ways that are burdensome, opaque, and financially damaging to providers, especially smaller and rural ones. They cited examples of multiple audit requests in short timeframes, large record requests with short deadlines, delayed or absent feedback, and recoupments taken before appeals are resolved. They also said parity laws are not being consistently enforced and that the bill would give the Department of Insurance authority to suspend or revoke an MCO certificate of authority for willful or repeated parity violations. Committee members generally expressed support for provider protections and transparency, while asking for clarification on the narcotic treatment and E/M billing provisions. Tom Stevens of the Kentucky Association of Health Plans testified in opposition, saying the bill is complex to implement and should be handled through the broader Medicaid oversight work of House Bill 9, the MOAB. He said the issues raised were better suited for that bipartisan stakeholder process and noted the committee substitute had not yet been fully reviewed by his group. After discussion, the committee adopted the committee substitute and then moved to a vote on the bill; the roll call began, with several members recorded as voting yes, but the transcript cuts off before the final vote result is shown.

Transcript Highlights:

• This bill applies skilled and trained workforce standards to pharmaceutical facilities.
• It actually applies skilled and trained workforce standards to pharmaceutical facilities.
• Pharmaceutical facilities are not typical construction projects.
• We appreciate the author's intent to ensure quality and safety in the construction of pharmaceutical
• We appreciate the author's intent to ensure quality and safety in the construction of pharmaceutical

Keywords: 987, senate, all

Transcript Highlights:

• But also, more importantly, through the Commerce Department and meeting directly with pharmaceutical
• We have 4.2% of the world's population and we take 50% of the pharmaceutical drugs.
• We're the only country that allows full-scale pharmaceutical ads on TV.
• Let's not just do something for the pharmaceutical company. So I appreciate you doing that.
• They did not come from the executives—not one nickel of PAC money from the pharmaceutical industry.

Transcript Highlights:

• the last 40 years, do you know how many heads of the FDA have not taken their next job with a pharmaceutical
• 2. 2, So to say that there's a problem with the pharmaceutical, and there's going to be huge amounts
• because I anticipate or I imagine that when a drug manufacturer develops a medication or some type of compound

Bills: HB 265, HB25

Keywords: youth camp, safety regulations, advisory committee, child welfare, health standards, summer camp, camp safety, child abuse reporting, child neglect, mandatory reporting, background check, criminal history check, sex offender registry, CPR training, first aid, public health, child protection, camp operator, camp counselor, Health and Safety Code

Transcript Highlights:

• It is the pharmaceutical companies that are the ones setting the high prices of drugs, and we're here
• </c> negotiate with the pharmaceutical negotiate with the pharmaceutical companies<00:31:01.039><c> to
• </c><00:33:15.240><c> companies</c> drugs it's the pharmaceutical companies drugs it's the pharmaceutical
• </c><00:36:02.119><c> prices</c> impact pharmaceutical prices impact pharmaceutical prices specifically
• </c><00:36:21.599><c> advertising</c> to me is the pharmaceutical advertising to me is the pharmaceutical

Keywords: Meeting Start: 00:00 Roll Call: 00:10 SB145 Discussion: 02:23 SB145 Vote: 05:13 SB183 Discussion: 06:13 SB183 Vote: 11:37 HB413 Discussion Only: 16:15, 958, all

Summary: The House Standing Committee on Banking and Insurance met with a quorum and first took up Senate Bill 145, sponsored by Sen. David Givens. The bill would update retail installment contract statutes for automobile sales, allowing retailers with installment contracts shorter than 28 days to begin collections after three days instead of waiting for multiple missed payments, and it also harmonizes a related dollar amount in statute from $10 to $15. The committee asked no questions, and the bill received a favorable expression on a roll-call vote. The committee then heard Senate Bill 183 from Sen. Matt Nunn, with testimony from Chris Nolan of the American Property Casualty Insurance Association. The bill would require proxy advisers acting for the State Retirement System to act solely in the financial interest of current and future retirees and to avoid political or social considerations in shareholder voting recommendations. Supporters argued it would keep politics out of public pensions and align proxy advice with fiduciary duties; members praised the bill and noted Kentucky could be among the first states to adopt such a model. The committee approved the bill with favorable expression after a roll-call vote. The committee also reviewed administrative regulation 808 KAR 9:10 from the Department of Financial Institutions, with no vote required. It then took up House Bill 413, a PBM rebate pass-through bill, with testimony from Sarah Wood of the Diabetes Patient Advocacy Coalition. She said the bill would require 85% of negotiated drug rebates to be passed through to patients at the point of sale, lowering out-of-pocket costs, especially for high-rebate drugs such as insulin, while still allowing 15% to remain with plans. She cited examples from other states and argued the bill would benefit about 650,000 Kentuckians. Hope McClaflin of Anthem opposed the bill, saying it would reduce employers’ ability to use rebates to lower premiums, could disproportionately favor high-cost brand-name drug users, and could create significant costs for state and fully insured plans. Members asked questions about other states’ pass-through rates and the effect on premiums, but no final action on House Bill 413 was taken in the portion of the meeting provided.

Transcript Highlights:

• But if it's being treated with pharmaceuticals, that costs money too.
• It costs money to provide pharmaceuticals for the chainsaw method.
• But if it's being treated with pharmaceuticals, that costs money too.
• It costs money to provide pharmaceuticals for the chainsaw method.
• It costs money to provide pharmaceuticals for the chainsaw method.

Keywords: 959, house, all

Transcript Highlights:

• </c><00:08:40.479><c> industry</c> mandated and the pharmaceutical industry mandated and the pharmaceutical
• </c><01:00:26.880><c> cartel</c> is that our pharmaceutical cartel is that our pharmaceutical cartel
• </c><01:13:01.280><c> industry</c> profits for the pharmaceutical industry profits for the pharmaceutical
• Does your organization take financial support from pharmaceutical companies?
• </c> pharmaceutical companies? pharmaceutical companies?

Keywords: 1189, house, all

Transcript Highlights:

• This bill costs the state nothing, and it is supported by the Pharmaceutical Association.
• somebody has maybe a learning disability or is autistic or has some sort of health condition that just compounds

Summary: The House first established a quorum, then heard a presentation from Debbie Huang of the Taipei Economic and Cultural Office in Denver. Huang thanked Missouri lawmakers for their annual Taiwan resolutions and described Taiwan as a democratic and economic partner of the United States, emphasizing cooperation with Missouri in agriculture, manufacturing, logistics, semiconductors, and AI, while also warning about pressure from China and the need for stronger Taiwan-U.S. ties. The chamber then took up House Bill 311, which would move oversight of bail bondsmen under the existing board for private investigators and fire investigators, add bail bondsmen to that board, and increase training and oversight. Members said the bill was industry-requested, had unanimous committee support, and carried no fiscal note. The House adopted the committee substitute and perfected and printed the bill. Lawmakers also debated and adopted a committee substitute for House Bill 3009, a pharmacy bill aimed at clarifying rules for pharmacies serving low-income and underserved patients, emergency medication dispensing, and out-of-state pharmacy accreditation. Amendments were adopted to update the title and align Missouri law with national pharmacy board accreditation standards. The bill was described as a response to access problems during the 2025 St. Louis tornado and was said to have no state cost. A large block of floor action followed on a combined package of bills and amendments covering public safety, criminal law, health, and licensing. Measures discussed and adopted included changes to the sex offender registry and related corrections, an offense for impeding first responders, Mason’s Law to flag drivers with disabilities in law enforcement databases, a hands-free cell phone law update, Highway Patrol equipment purchasing authority, psilocybin language for first responders and veterans, AI-generated explicit material and child pornography provisions, gift card fraud penalties, stronger fentanyl trafficking penalties, Melanie’s Law on ignition interlock/DUI penalties, a domestic violence registry, boiler inspection and Missouri fire/life safety standards, Kansas City police retirement age corrections, and a commercial driver English proficiency bill with stronger penalties for drivers and carriers. One amendment on the sex offender registry was withdrawn after debate, and the House ultimately adopted the remaining amendments and referred the combined House Bills 368 and 3049 substitute to the Committee on Legislative Review.

Transcript Highlights:

• In this, The help comes from a pharmaceutical company, who has an interest in helping because they want
• Is this going to be killing generic competition in the state with regard to these pharmaceuticals?
• Is this going to be killing generic competition in the state with regard to these pharmaceuticals?
• Is this going to be killing generic competition in the state with regard to these pharmaceuticals?
• I'm not able, as I stand here today, ...to isolate down to just the pharmaceutical benefit.

Summary: The committee first introduced RS 33403, a follow-on podiatry bill that would merge podiatry with the Board of Medicine and move certain rules into statute. Representative Ehlers explained it was a replacement for prior legislation, and the committee voted to introduce it without objection. The committee then heard House Bill 713 on copay accumulator policies. Representative Cannon and co-sponsor Representative Furman argued the bill would stop insurers from refusing to count third-party copay assistance toward deductibles and out-of-pocket maximums, especially for patients with expensive specialty drugs. Supporters, including patients and advocates, described serious financial hardship and treatment adherence problems caused by accumulators. Opponents, including the Idaho Association of Health Plans, argued the bill would raise costs and premiums, could conflict with Idaho’s anti-kickback law, and might interfere with private plan design. After debate, the committee voted 7-8 against the motion to send HB 713 to the floor, so the bill was held in committee. Next, the committee took up House Bill 655 and its related RS 33527, a pilot program to incentivize preceptorships by giving certain Medicaid providers a 12-month exemption from prior authorization requirements. The sponsor said the goal was to reduce administrative burden and increase training opportunities in rural areas and in family practice, psychiatry, and OB-GYN, with caps on participation and expansion to advanced practice providers and PAs in the RS. The committee first voted to hold HB 655 in committee, then approved RS 33527 for introduction and second reading. Finally, the committee heard House Bill 723 on children’s residential facilities. Representative Erickson said the bill would add quality-of-care oversight, annual unannounced inspections, resident and staff interviews, a youth bill of rights, and critical incident reporting, based on an OPE study and prior testimony about abuse and gaps in oversight. Testifiers, including parents and former residents, described abuse, isolation, and lack of reporting mechanisms in facilities and supported the bill. The committee discussed whether the bill created enforceable rights, but the sponsor said existing child protection and corrective action processes would apply. The bill was moved to the floor with a due pass recommendation.